Jump to content

Lung Cancer Canada requesting our help Re: Nivolumab (Opdivo)


Recommended Posts

HI All- 

Our friends at LCC need our help on immunotherapy 

See below:


Please Share Your Insights on Nivolumab! (Opdivo)

Canada is evaluating nivolumab for public coverage and we need your help. We are looking for patients and caregivers who have had experience with nivolumab in NSCLC. The Pan-Canadian Oncology Drug Review (pCORDR) group is a government organization that decides if nivolumab should receive public coverage. It is an important step to getting access in Canada. Lung Cancer Canada completes the patient and caregiver experience portion of that submission. We are looking for patients and caregivers who have experience with Nivolumab to speak to us either one on one or in a group discussion. It should take no more than 60 minutes of your time. We will work around your availability. You don’t have to be Canadian to participate. pCODR considers the patient experience to be the patient experience. We would need to speak to you by November 10.

Thanks for your help. Please connect with christina@lungcancercanada.ca if you are able to help!!!!


Link to comment
Share on other sites

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Reply to this topic...

×   Pasted as rich text.   Restore formatting

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

  • Create New...

Important Information

By using this site, you agree to our Terms of Use.